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Abstract: 
AccD6 (acetyl coenzyme A (CoA) carboxylase), plays an important role in mycolic acid synthesis of Mycobacterium tuberculosis 
(Mtb). Induced gene expression by isoniazid (isonicotinylhydrazine - INH), anti-tuberculosis drug) shows the expression of accD6. 
It is our interest to study the binding of activated INH with the AccD6 model using molecular docking procedures. The study 
predicts a primary binding site for activated INH (isonicotinyl acyl radical) in AccD6 as a potential target.  
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Background: 
Tuberculosis (TB) still remains as a major public health 
problem, despite of significant improvement and advancement 
made in the field of diagnosis and therapeutics. INH 
(isonicotinic acid Hydrazide) is the cornerstone of treatment for 
drug-susceptible TB and it is also widely used to treat latent 
Mtb infection. There has been considerable interest to know the 
molecular basis of INH resistance, which is less well 
characterized and mutations in several genes have been 
associated with it. It is proposed that INH enters Mtb  as a 
prodrug by passive diffusion and is activated by  catalase-
peroxidase, encoded by katG [1], to generate free radicals, which 
then attack multiple targets in the cells. Initial studies utilizing 
whole cells of Mtb  demonstrated that INH was principally 
metabolized to several products, including 4-pyridylmethanol 
and isonicotinic acid. The authors speculated that INH could be 
oxidized in vivo to yield a number of highly reactive species, 
including diazenyl, hydrazide, or acyl radicals, which could 
t h e n  g o  o n  t o  o x i d i z e  o r  a c ylate groups in proteins. The 
aldehyde, fed exogenously, is quickly reduced to the alcohol [2] 
while in the in vitro system with Mn++ presence, the aldehyde 
has been reported to undergo oxidation to the acid and in the 
presence of Mn++, the addition of simple amines results in the 
efficient formation of the corresponding amides [3]. One 
metabolite in vitro from INH conversion in the presence of 
nicotinamide adenine dinucleotide (NAD+) (and Mn++) is the 
c o v a l e n t  a d d u c t  o f  t h e  a c y l  p y r i d i n e  f r o m  I N H  a n d  t h e  
nicotinamide ring system [4]. It has been proposed to be 
important in inhibiting one of the cellular targets associated 
with mycolic acid synthesis, InhA [5]. Studies have shown that 
an NADH-dependent enoyl acyl carrier  protein (ACP) 
reductase, encoded by inhA, and ketoacyl  ACP synthase, 
encoded by kasA, are two potential intracellular enzymatic 
targets for activated INH; and both of these enzymes are 
involved in the biosynthesis of mycolic acids [6, 7].   
 
The recent microarray approach has generated new insights 
into the action of INH and shows that INH induces several 
genes, including kasA and B, fabD, efpA and accD6, which are 
presumably involved in fatty acid oxidation [8, 9]. Of which, 
accD6, plays an important role in mycolic acid synthesis. Mtb 
contains six Acyl-CoA carboxylases  (ACCase) 
carboxyltransferase  domains,  accD1–6, whose specific roles in 
the pathogen is not well defined but they are important for cell BIOINFORMATION  open access 
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envelope lipid biosynthesis and  that its disruption leads to 
pathogen death [11]. The Mtb  genome contains three biotin 
carboxylase subunits (AccA1 to -3) and six carboxyltransferase 
subunits (AccD1 to -6), with accD6 located in a genetic locus that 
contains members of the fatty acid synthase II (FAS II) complex. 
accA3,  accD4,  accD5, and  accD6 are expressed at high levels 
during the exponential growth  phases of Mtb in vitro. Micro 
array analysis of Mtb transcripts indicated that the transcripts 
for accA3, accD4, accD5, accD6, and accE were repressed during 
later growth stages. The accD4 and accD5 have been previously 
studied, and the function of accD6 designated as a member of 
the FAS II locus, is a functional carboxyltransferase subunit of 
the ACCase in Mtb [12].    
 
Previous studies using microarray technique have [8-10] 
provided the information regarding the up regulation of AccD6 
upon exposure to INH. The present study was aimed to 
computationally analyze the binding ability of AccD6, via 
modeling of AccD6 and docking with activated INH products 
such as isonicotinic acid, isonicotinaldehyde, isonicotinamide 
and isonicotinyl acyl radical (INADH).  The study is first of its 
kind to provide structural details of AccD6 as a target in 
addition to InhA and its interaction with the activated INH.   
 
Methodology: 
Homology modeling of AccD6:  
Modeling was performed using MODELLER 9v3 [13] by the 
following steps: 1. Template Selection: The target protein AccD6 
was submitted to protein based Basic Local Alignment Search 
Tool BLASTp [14] from National Center for Biotechnology 
Information (NCBI) database and was searched against Protein 
Data Bank (PDB). It showed a percentage identity of 43% with 
the template protein AccD5 (PDB code-2A7S) that belongs to 
same group of AccD6. 2. Target-template alignment: The target-
template alignment was done using the MODELLER command 
line with the language python. 3. Model Building: The refined 
sequence-structure alignment as obtained by MODELLER was 
used to construct 3D models of the target with the help of the 
known structures of the template. 4. Model Validation of the 
models was done by Ramachandran plot [15] Combinatorial 
Extension (CE) [16] and Discrete optimized protein energy 
(DOPE) feature in Discovery Studio (DS) [17]. The model was 
validated to eliminate the structural errors present in the 
generated model and to improve its quality and stability.   
 
Docking of activated INH with AccD6: 
Docking was performed using CDOCKER [18]. The ligand with 
all H atoms was built using DS. The AccD6 model was energy 
minimized with CHARMm force field before performing 
docking. The ligands comprises of activated form of INH 
including INADH, isonicotinic acid, isonicotinaldehyde, 
isonicotinamide and acetyl-CoA. The CDOCKER protocol is an 
implementation of the CDOCKER algorithm in the Discovery 
Studio (DS) environment. It allows running a refinement 
docking of any number of ligands with a single protein 
receptor. CDOCKER is a grid-based molecular docking method 
that employs CHARMm. The receptor is held rigid while the 
ligands are allowed to flex during the refinement. Docking was 
done using the default settings. The default speed selection was 
used to avoid a potential reduction in docking accuracy. There 
are two methods employed to define the site: a) Finding sites 
from the receptor cavities (b) Defining the site as the volume of 
a selected ligand.  
Results and Discussion: 
Homology Modeling: 
In the present study, the structure of AccD6 (an important 
enzyme for mycolic acid synthesis in Mtb) was modeled due to 
the lack of crystal structure in the PDB. Modeling of AccD6 
enables to understand its role in binding of activated INH 
(INADH). We provided structural details of AccD6 and its 
interaction with the activated INH. In the results of BLAST 
search against PDB, 2A7S was identified as the template 
protein, which had a sequence identity of 43% with AccD6 of 
Mtb.  The aligned target and the template sequences were in 
PIR format.   The template sequence was submitted to Pfam, 
PROSITE databases. The pattern, profiles and the domains 
obtained were compared with the target sequence. The target 
sequence was found to contain carboxyl transferase domain, 
which spans a region of 1-471, and in template the same domain 
spans a region of 46-546 amino acids. Amino acid sequence of 
the target was aligned to the template sequence based on the 
secondary structure information for building an accurate model 
by ClustalW. The model generated by the above method was 
subjected to validation using the following softwares:  I) 
Ramachandran Plot using RAMPAGE server: The 
Ramachandran plot for the modeled structure showed 92% of 
the residues in the most favored region, 5.8% in the additional 
allowed region, and 2.3% in the generally allowed region and 
no residues in the unfavorable region. II) CE (Combinatorial 
Extension) method: The model obtained was evaluated using 
CE method. Structurally conserved regions (SCRs) for the target 
sequence and the templates were determined by 
superimposition of two structures through sequence alignment. 
The root mean square deviation (RMSD) score was calculated 
using the sequence identity and gaps in the alignment 
displaying RMSD value of 1.0 Å and Z-score of 8.0. III) ERRAT: 
The structure was submitted to structural analysis and 
validation server (SAVS), the ERRAT score for the protein was 
found to be 75.01%. d) DOPE score:  Five  models  were 
generated by the modeling option in the DS environment for 
AccD6. Out of these; one of the models with highest dope score 
of -46172.78 was selected for docking. 
 
 
Figure 1: Monomeric structure of AccD6 showing the active site 
residues (green) in a) stick model and helices are labeled, b) 
space filled model. 
 
The initial model was thus generated with the above procedure. 
As AccD6 is a hexameric protein, modeling all the six chains in 
a single MODELLER program was tedious so each chain was 
sequentially modeled as described above. The atom files of all 
the six chains (ABCDE and F) modeled sequentially was 
compiled as a single file to obtain the hexameric structure of the 
protein.  The modeled AccD6 was found to contain 25 helices 
and beta sheets and 51 turns in a single chain. The amino acids BIOINFORMATION  open access 
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at the ligand-binding site (i.e. active site) were analyzed to be 
Met64, Ala67, Gly97, Gly98, Ala99, Arg100, Leu101, Leu108, 
Gly137 and Gly138 which could be the key residues for its 
catalytic function (Figure 1).      
 
Docking of AccD6 with activated INH: 
The model AccD6 was docked with acetyl-CoA and active 
forms of INH viz; INADH, isonicotinic acid, 
isonicotinaldehyde, isonicotinamide using CDOCKER. The 
values suggest that the ligand INADH could be the correct 
inhibitor for AccD6 compared to others. We therefore speculate 
that the higher score (69.92kcal/mol) in case of INADH could 
be better one on the basis of good-fit, wherein the AccD6 
contains sufficient binding space (cleft) enabling the INADH 
moiety to fit in perfectly. The other smaller molecules 
(isonicotinic acid, isonicotinaldehyde, isonicotinamide) were 
unable to produce higher score due to the spatial inconsistency. 
Supportingly, the obtained score for INADH was similar to 
acetyl-CoA (substrate) reinforcing the concept of good inhibitor 
compared to others (Table 1, see Supplementary material). 
Since INADH has structural complexity similar to acetyl-CoA, 
also that it produced similar score to that of acetyl-CoA 
compared to others, which signifies the classical concept of 
inhibitor design on the basis of substrate similarity (Figure 2). 
 
 
Figure 2: Structural similarity between a) Acetyl-CoA and b) 
INADH 
 
The   H bond profile at the ligand binding sites of AccD6 with 
INADH and acetyl-CoA was illustrated in Figure 3 and Table 2 
(see Supplementary material). The H bond profile of AccD6 at 
the ligand binding sites indicates residues such as Leu101, 
Ala102, and Gly138 forms 3 H bonds with atoms of INADH 
molecule whereas the profile for acetyl-CoA indicates 1 H bond 
formation with residue Ala99.  No H bond was found with the 
other ligands such as isonicotinic acid, isonicotinaldehyde, 
isonicotinamide. Thus, more number of H bonds in the INADH 
molecule also indicates that it is a good inhibitor for the target 
(AccD6). Hence the score and H bond profile suggests that 
AccD6 has more binding affinity towards INADH, therefore 
these observations  correlates with  earlier reports [4, 5] that the 
gene accD6 is switched on during INH exposure. 
  
INH has multiple effects on the tubercle bacillus, and its activity 
resulting in cell death is still unclear. One of the first 
consequences of INH action on Mtb to be noticed was the loss of 
acid fastness, and this was shown to result from inhibition of 
the synthesis of mycolic acids [19]. These long-chain, 
unsaturated fatty acids, which contribute to the impermeability 
of the cell envelope, are confined essentially to mycobacteria 
and are thus a selective target for drugs. The best-known target 
is the cell wall mycolic acid synthesis pathway [20], where 
atleast two enzymes, InhA and KasA have been identified as 
targets for INH activation. However, in the present study, 
AccD6 is identified as the target for INADH. It was speculated 
that the active form of INH ranged from production of 
nonspecifically toxic free radical species to the generation of a 
range of reactive (both reactive oxygen and organic) radicals, 
which then attack multiple targets in the tubercle bacillus [21]. 
In relation to which, in the present study, the active species 
such as isonicotinic acid, isonicotinaldehyde, isonicotinamide 
and INADH were taken into account.       
 
 
Figure 3: H bond display indicated in blue dotted lines of 
AccD6 with a) acetyl-CoA; b) INADH; c) Isonicotinamide; d) 
isonicotinaldehyde; e) Isonicotinic acid  
 
Conclusion:           
In conclusion, we have presented the model structure of AccD6 
and predicted its binding ability with INADH, suggesting that 
AccD6 could also be the target for INADH in addition to InhA. 
There are still many avenues to be explored using AccD6 as a 
new target for the structure-based development of novel anti- 
mycobacterial drugs [22] since  it has been involved in cell wall 
synthesis. This study adds new knowledge in the research area 
of identification of additional targets for activated INH, and is 
in agreement with the report [23] which suggests that the 
identification of additional targets for activated INH is an 
important future endeavour. 
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Supplementary material: 
 
Table 1: Docking score 
Ligands Score  (kcal/mol) 
Acetyl-CoA  66.14 
INADH                            69.92 
Isonicotinic acid             11.27 
Isonicotinaldehyde        4.69 
Isonicotinamide  3.80 
 
Table 2: H bond profile at the ligand binding site 
Ligands   No. of Hb   Hb donor   Hb acceptor    Bond distance (Å) 
Acetyl-CoA                  1      ALA99:HN 
ALA107:HN 
GLY137:HN 
aco4:O26 
GLY104:O 
PHE158:O 
2.10  
2.22  
2.17 
INADH                   3  LEU101:HN 
ALA102:HN 
ALA107:HN 
GLY138:HN 
INADH:O40 
INADH:O40 
GLY104:O 
INADH:O3  
2.23  
2.21  
2.22  
2.06 
Isonicotinic acid 
 
 GLU103:HN 
GLY104:HN 
ALA107:HN 
ARG100:O 
LEU101:O 
GLY104:O 
2.30                        
1.98  
2.22 
Isonicotinaldehyde    ALA107:HN      GLY104:O  2.22 
Isonicotinamide    ALA107:HN      GLY104:O  2.22 
Hb = Hydrogen bonds, aco4 = acetyl-CoA, A = Amstrong 
                                  
 
 
 
 
 
 
 
 
 
 
 
 